Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,695.00
+15.00 (0.41%)
At close: Apr 10, 2026

KOSDAQ:142280 Revenue

In the year 2025, Green Cross Medical Science had annual revenue of 108.41B KRW with 4.39% growth. Green Cross Medical Science had revenue of 25.05B in the quarter ending December 31, 2025, a decrease of -9.74%.

Revenue
108.41B
Revenue Growth
+4.39%
P/S Ratio
0.74
Revenue / Employee
888.63M
Employees
122
Market Cap
80.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025108.41B4.56B4.39%
Dec 31, 2024103.85B9.84B10.47%
Dec 31, 202394.01B-19.10B-16.88%
Dec 31, 2022113.11B11.43B11.25%
Dec 31, 2021101.67B-11.70B-10.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seoulin Bioscience77.09B
Dx & Vx29.36B
Cytogen26.05B
Protia15.12B
HLB Panagene15.05B
3billion11.71B
GENINUS10.48B
Median Diagnostics7.86B
Revenue Rankings